Header Logo

Connection

Jaejin An to Female

This is a "connection" page, showing publications Jaejin An has written about Female.
Connection Strength

1.726
  1. Cardiovascular and Kidney Events Associated with Visit-to-Visit Blood Pressure Variability among Young Adults with Hypertension. Am J Hypertens. 2026 Aug 01; 39(8):988-996.
    View in: PubMed
    Score: 0.084
  2. Sex Differences in Hypertension Diagnosis Among Young Adults in a US Integrated Health Care System. J Am Heart Assoc. 2026 08 04; 15(15):e042879.
    View in: PubMed
    Score: 0.084
  3. Trends in Initial Combination Antihypertensive Therapy in a US Health System. Am J Hypertens. 2026 Jun 01; 39(6):787-796.
    View in: PubMed
    Score: 0.083
  4. Validation of electronic health record-based International Society on Thrombosis and Haemostasis bleeding algorithms in a US health system. Res Pract Thromb Haemost. 2026 May; 10(4):106616.
    View in: PubMed
    Score: 0.082
  5. Cost-effectiveness of implementing a home blood pressure telemonitoring program. Am J Manag Care. 2026 Mar; 32(3):146-152.
    View in: PubMed
    Score: 0.081
  6. PREVENT Equation Performance in Asian and Native Hawaiian and Other Pacific Islander Groups. JAMA Netw Open. 2026 02 02; 9(2):e2556915.
    View in: PubMed
    Score: 0.081
  7. Factors Associated with Treatment Intensification for Uncontrolled Hypertension in a US Health System. J Gen Intern Med. 2026 05; 41(7):1881-1891.
    View in: PubMed
    Score: 0.080
  8. Follow-Up Lipid Testing and Statin Initiation Among Young Adults in a U.S. Health Care System. J Am Coll Cardiol. 2026 Mar 24; 87(11):1327-1339.
    View in: PubMed
    Score: 0.080
  9. Development and Validation of an Incident Hypertension Risk Prediction Model for Young Adults. J Am Heart Assoc. 2025 Jul 15; 14(14):e040769.
    View in: PubMed
    Score: 0.078
  10. Evaluation and Comparison of the PREVENT and Pooled Cohort Equations for 10-Year Atherosclerotic Cardiovascular Risk Prediction. J Am Heart Assoc. 2025 Feb 18; 14(4):e039454.
    View in: PubMed
    Score: 0.076
  11. Blood Pressure Reduction and Changes in Antihypertensive Medication Use Among Patients With Hypertension Who Initiated Sodium-Glucose Cotransporter-2 Inhibitors. J Clin Hypertens (Greenwich). 2024 Nov; 26(11):1318-1321.
    View in: PubMed
    Score: 0.074
  12. Prevalence and incidence of microvascular and macrovascular complications over 15 years among patients with incident type 2 diabetes. BMJ Open Diabetes Res Care. 2021 01; 9(1).
    View in: PubMed
    Score: 0.057
  13. Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID-19 Infection Among 824 650 Patients With Hypertension From a US Integrated Healthcare System. J Am Heart Assoc. 2021 02 02; 10(3):e019669.
    View in: PubMed
    Score: 0.057
  14. Recurrent Atherosclerotic Cardiovascular Event Rates Differ Among Patients Meeting the Very High Risk Definition According to Age, Sex, Race/Ethnicity, and Socioeconomic Status. J Am Heart Assoc. 2020 12; 9(23):e017310.
    View in: PubMed
    Score: 0.057
  15. Treatment Patterns and Blood Pressure Control With Initiation of Combination Versus Monotherapy Antihypertensive Regimens. Hypertension. 2021 01; 77(1):103-113.
    View in: PubMed
    Score: 0.056
  16. Impact of pill burden on adherence to hepatitis C medication. Curr Med Res Opin. 2019 11; 35(11):1937-1944.
    View in: PubMed
    Score: 0.052
  17. Prevalence of comorbidities and their associations with health-related quality of life and healthcare expenditures in patients with rheumatoid arthritis. Clin Rheumatol. 2019 Oct; 38(10):2717-2726.
    View in: PubMed
    Score: 0.051
  18. Association between different types of comorbidity and disease burden in patients with diabetes. J Diabetes. 2019 Jan; 11(1):65-74.
    View in: PubMed
    Score: 0.048
  19. Adherence to the American Diabetes Association retinal screening guidelines for population with diabetes in the United States. Ophthalmic Epidemiol. 2018 06; 25(3):257-265.
    View in: PubMed
    Score: 0.046
  20. Warfarin Management and Outcomes in Patients with Nonvalvular Atrial Fibrillation Within an Integrated Health Care System. J Manag Care Spec Pharm. 2017 Jun; 23(6):700-712.
    View in: PubMed
    Score: 0.044
  21. The Impact of Patient-Centered Medical Homes on Quality of Care and Medication Adherence in Patients with Diabetes Mellitus. J Manag Care Spec Pharm. 2016 Nov; 22(11):1272-1284.
    View in: PubMed
    Score: 0.043
  22. Cardiovascular Outcomes Associated with Lowering Low-density Lipoprotein Cholesterol in Rheumatoid Arthritis and Matched Nonrheumatoid Arthritis. J Rheumatol. 2016 11; 43(11):1989-1996.
    View in: PubMed
    Score: 0.042
  23. Traditional Cardiovascular Disease Risk Factor Management in Rheumatoid Arthritis Compared to Matched Nonrheumatoid Arthritis in a US Managed Care Setting. Arthritis Care Res (Hoboken). 2016 05; 68(5):629-37.
    View in: PubMed
    Score: 0.041
  24. Stroke and Bleeding Risk Associated With Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation in Clinical Practice. J Am Heart Assoc. 2015 Jul 17; 4(7).
    View in: PubMed
    Score: 0.039
  25. Multiple medication adherence and its effect on clinical outcomes among patients with comorbid type 2 diabetes and hypertension. Med Care. 2013 Oct; 51(10):879-87.
    View in: PubMed
    Score: 0.034
  26. Comparison of Healthcare Resource Utilization and Disease Outcomes in Adults Hospitalized with Human Metapneumovirus and Respiratory Syncytial Virus. J Infect Dis. 2026 Mar 17; 233(3):e651-e661.
    View in: PubMed
    Score: 0.020
  27. Clinical and Demographic Characteristics Associated With Diabetes Remission in Six Integrated Health Care Systems: A Retrospective Cohort Study. Diabetes Care. 2025 Oct 01; 48(10):1737-1743.
    View in: PubMed
    Score: 0.020
  28. Glucose-Lowering Medication Classes and Cardiovascular Outcomes in Patients With Type 2 Diabetes. JAMA Netw Open. 2025 10 01; 8(10):e2536100.
    View in: PubMed
    Score: 0.020
  29. PREVENT and PCE Models for Estimating ASCVD Risk Stratified by Statin Exposure. JAMA Netw Open. 2025 Sep 02; 8(9):e2532164.
    View in: PubMed
    Score: 0.020
  30. GLP-1RA comparative effectiveness against dementia onset relative to other antidiabetic medications in a large, multi-site cohort of patients with type 2 diabetes. Alzheimers Dement. 2025 Sep; 21(9):e70621.
    View in: PubMed
    Score: 0.020
  31. Blood Pressure Control Among Black and White Adults Following a Quality Improvement Program in a Large Integrated Health System. JAMA Netw Open. 2023 01 03; 6(1):e2249930.
    View in: PubMed
    Score: 0.016
  32. Comparison of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Bioprosthetic Heart Valves. Am J Cardiol. 2021 05 01; 146:22-28.
    View in: PubMed
    Score: 0.014
  33. Cost of Hospitalization Associated With Respiratory Syncytial Virus Infection Versus Influenza Infection in Hospitalized Older Adults. J Infect Dis. 2020 08 17; 222(6):962-966.
    View in: PubMed
    Score: 0.014
  34. Treatment discontinuation of oral hypoglycemic agents and healthcare utilization among patients with diabetes. J Diabetes Complications. 2016 Nov - Dec; 30(8):1443-1451.
    View in: PubMed
    Score: 0.010
  35. The impact of value-based benefit design on adherence to diabetes medications: a propensity score-weighted difference in difference evaluation. Value Health. 2010 Sep-Oct; 13(6):846-52.
    View in: PubMed
    Score: 0.007
  36. Clinical features of patients with a myocardial infarction during acute management of an ischemic stroke. Neurocrit Care. 2008; 9(3):332-7.
    View in: PubMed
    Score: 0.006
  37. The leukoaraiosis is more prevalent in the large artery atherosclerosis stroke subtype among Korean patients with ischemic stroke. BMC Neurol. 2008 Aug 07; 8:31.
    View in: PubMed
    Score: 0.006

© 2026 Kaiser Permanente

Your Privacy Choices